ClinicalTrials.gg
Drug

Nadroparin clinical trials

Also written Fraxiparin and Fraxiparine.

studies test it
20
open now
1
in phase 3
6
first study started
2002

How each study uses Nadroparin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Nadroparin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nadroparin
10
Nadroparin calcium
3

Brand

Fraxiparin
4

Other names

Fraxiparine
2

In one entry with another drug

Given together, or one or the other

Nadroparin Calcium and Warfarin
3

Studies by the year they started

19 studies that test it; most in 2013 (4)

Studies that test Nadroparin, by start year
YearStudies
20021
20032
20061
20082
20091
20101
20111
20134
20153
20161
20171
20221

By phase

A phase 1/2 study counts in both.

Phase 2
2
Phase 3
6
Phase 4
10
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 18

Shanghai Zhongshan Hospital (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Clinique Saint Pierre Ottignies (1) · Qilu Hospital of Shandong University (1) · Martini Hospital Groningen (1) · University Hospital, Geneva (1) · GlaxoSmithKline (1) · Italfarmaco (1)

Often tested with

Tested in the same studies.

Warfarin (4) · Fondaparinux (2) · Enoxaparin (1) · Dalteparin (1) · Tinzaparin (1) · Dabigatran (1) · Rivaroxaban (1) · Trisodium citrate (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Nadroparin is the comparator. A study of two new drugs counts under both.

  • 2Rivaroxaban · Second Affiliated Hospital, School of Medicine, Zhejiang University

Studies

Open first, then newest update. How each study uses Nadroparin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 20

Given beside what is tested · 1 — Nadroparin is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Nadroparin

Codes

What other systems call Nadroparin · ClinicalTrials.gg INT008612

  • MeSH (NLM) D017762NadroparinConfirmed ClinicalTrials.gov, Wikidata
  • UNII (FDA) 1K5KDI46KZNADROPARINConfirmed FDA, Wikidata
  • RxNorm 67031One source FDA
  • Wikidata Q20817257nadroparinConfirmed FDA, Wikidata
  • NCI Thesaurus C200713NadroparinOne source FDA
  • DrugBank DB08813One source Wikidata

Also registered as nadroparin calcium (UNII LIA7Z4002P).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.